Yseop Leverages AI to Accelerate Pharma Clinical Trials While Ensuring Accuracy and Security
-
Pharma clinical trials present an opportunity for AI to analyze massive amounts of data and accelerate regulatory submissions. However, the AI must be accurate, secure, and controllable.
-
Yseop is an AI software company targeting the clinical trials industry to reduce the 28 week timeline from database lock to submission.
-
AI models cannot make mistakes, leak sensitive data, or act as inscrutable black boxes. They must instill confidence and be easy to use.
-
Yseop combines multiple AI approaches, champion users, change management, and continuous improvement to increase adoption.
-
With over 10,000 reports generated for industry leaders in 2022 alone, Yseop has shown strong early traction in pharma AI.